Skip to content
1887

Abstract

Hepatitis E virus (HEV) is a major cause of acute hepatitis worldwide. While faecal–oral transmission is well-established, the potential for sexual transmission remains unclear. This study aimed to investigate whether HEV can be transmitted through sexual routes using a rabbit model. A total of 80 rabbits were inoculated intravaginally or intrarectally with HEV, compared to intravenous challenge. To assess hormonal influence, rabbits were pre-treated with medroxyprogesterone acetate (MPA) or pregnant mare serum gonadotrophin (PMSG) prior to vaginal inoculation. Also, 12 pregnant rabbits were injected with HEV by vaginal and intravenous routes, respectively, to evaluate adverse outcomes. Viral shedding, seroconversion, viral loads in tissues, histopathology and vaginal microbiota were analysed. Our results showed that HEV can be transmitted through both vaginal and rectal routes, establishing productive but less efficient infections than intravenous inoculation. Crucially, the MPA dramatically enhanced vaginal susceptibility, leading to prolonged viral shedding, higher systemic viral loads and 100% seroconversion, compared to partial infection in PMSG-treated and untreated controls. Vaginal infection in pregnant rabbits resulted in significant adverse outcomes, including abortion (66.7%) and vertical transmission. Furthermore, vaginal inoculation altered the local microbiota and transcriptome, suggesting a remodelled genital tract microenvironment. Our study provided the first direct experimental evidence that HEV can be sexually transmitted via vaginal and rectal routes. The progesterone-mediated enhancement of susceptibility and the severe pregnancy outcomes highlighted its public health risk, particularly for women.

Funding
This study was supported by the:
  • National Natural Science Foundation of China (Award 82202504)
    • Principal Award Recipient: ManyuLi
  • National Postdoctoral Program for Innovative Talents (Award 88032Y0008)
    • Principal Award Recipient: QiyuHe
  • China Postdoctoral Science Foundation (Award 88014Y0236)
    • Principal Award Recipient: QiyuHe
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.002231
2026-04-01
2026-04-22

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jgv/107/4/jgv002231.html?itemId=/content/journal/jgv/10.1099/jgv.0.002231&mimeType=html&fmt=ahah

References

  1. Horvatits T, Schulze Zur Wiesch J, Lütgehetmann M, Lohse AW, Pischke S. The clinical perspective on hepatitis E. Viruses 2019; 11:617 [View Article] [PubMed]
    [Google Scholar]
  2. Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol 2018; 15:96–110 [View Article] [PubMed]
    [Google Scholar]
  3. Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A et al. Hepatitis E virus infection. Nat Rev Dis Primers 2017; 3:17086 [View Article] [PubMed]
    [Google Scholar]
  4. Pérez-Gracia MT, Suay-García B, Mateos-Lindemann ML. Hepatitis E and pregnancy: current state. Rev Med Virol 2017; 27:e1929 [View Article] [PubMed]
    [Google Scholar]
  5. Horvatits T, Wißmann J-E, Johne R, Groschup MH, Gadicherla AK et al. Hepatitis E virus persists in the ejaculate of chronically infected men. J Hepatol 2021; 75:55–63 [View Article] [PubMed]
    [Google Scholar]
  6. Schemmerer M, Bock HH, Schattenberg JM, Huber S, Polywka S et al. Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients. J Med Virol 2024; 96:e29735 [View Article] [PubMed]
    [Google Scholar]
  7. Cong C, Xia Y, Gong S, Li T, Liu H et al. Infectious hepatitis E virus excreted into the vagina. FASEB J 2024; 38:e23500 [View Article] [PubMed]
    [Google Scholar]
  8. Li M, Bu Q, Gong W, Li H, Wang L et al. Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. J Matern Fetal Neonatal Med 2020; 33:3647–3651 [View Article] [PubMed]
    [Google Scholar]
  9. Qian Z, Li T, Xia Y, Cong C, Chen S et al. Genotype 4 Hepatitis E virus replicates in the placenta, causes severe histopathological damage, and vertically transmits to fetuses. J Infect 2023; 87:34–45 [View Article] [PubMed]
    [Google Scholar]
  10. Xia Y, Yang W, Li Y, Qian Z, Chen S et al. Severe maternal-fetal pathological damage and inflammatory responses contribute to miscarriage caused by hepatitis E viral infection during pregnancy. Liver Int 2023; 43:317–328 [View Article] [PubMed]
    [Google Scholar]
  11. Senise J, Bonafé S, Castelo A. The management of HIV-infected pregnant women. Curr Opin Obstet Gynecol 2012; 24:395–401 [View Article] [PubMed]
    [Google Scholar]
  12. Zhao Z, Li Q, Ashraf U, Yang M, Zhu W et al. Zika virus causes placental pyroptosis and associated adverse fetal outcomes by activating GSDME. Elife 2022; 11:e73792 [View Article] [PubMed]
    [Google Scholar]
  13. Duggal NK, McDonald EM, Ritter JM, Brault AC. Sexual transmission of Zika virus enhances in utero transmission in a mouse model. Sci Rep 2018; 8:4510 [View Article] [PubMed]
    [Google Scholar]
  14. Sakkas H, Bozidis P, Giannakopoulos X, Sofikitis N, Papadopoulou C. An update on sexual transmission of Zika virus. Pathogens 2018; 7:66 [View Article] [PubMed]
    [Google Scholar]
  15. Cherenack EM, Broedlow CA, Klatt NR. The vaginal microbiome and HIV transmission dynamics. Curr Opin HIV AIDS 2024; 19:234–240 [View Article] [PubMed]
    [Google Scholar]
  16. Lebeau A, Bruyere D, Roncarati P, Peixoto P, Hervouet E et al. HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nat Commun 2022; 13:1076 [View Article] [PubMed]
    [Google Scholar]
  17. Li M, Li S, He Q, Liang Z, Wang L et al. Hepatitis E-related adverse pregnancy outcomes and their prevention by hepatitis E vaccine in a rabbit model. Emerg Microbes Infect 2019; 8:1066–1075 [View Article] [PubMed]
    [Google Scholar]
  18. He Q, Liu T, Yang X, Yuan D, Lu Q et al. Optimization of immunosuppression strategies for the establishment of chronic hepatitis E virus infection in rabbits. J Virol 2024; 98:e0084624 [View Article] [PubMed]
    [Google Scholar]
  19. Mahsoub HM, Heffron CL, Hassebroek AM, Sooryanarain H, Wang B et al. Fetal loss in pregnant rabbits infected with genotype 3 hepatitis E virus is associated with altered inflammatory responses, enhanced virus replication, and extrahepatic virus dissemination with positive correlations with increased estradiol level. mBio 2023; 14:e0041823 [View Article] [PubMed]
    [Google Scholar]
  20. Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006; 131:65–71 [View Article] [PubMed]
    [Google Scholar]
  21. Zhang Y, Gong W, Song WT, Fu H, Wang L et al. Different susceptibility and pathogenesis of rabbit genotype 3 hepatitis E virus (HEV-3) and human HEV-3 (JRC-HE3) in SPF rabbits. Vet Microbiol 2017; 207:1–6 [View Article] [PubMed]
    [Google Scholar]
  22. Anzaldúa Arce SR, Mendoza-Rodríguez CA, Camacho-Arroyo I, Cerbón M, Pérez-Martínez M. Progesterone receptor immunoreactivity differs in the uterus of pseudopregnant and medroxyprogesterone acetate-treated rabbits. Anim Reprod Sci 2010; 120:173–178 [View Article]
    [Google Scholar]
  23. YoungLai EV. Effects of pregnant mare’s serum gonadotrophin administered in vivo on steroid accumulation by isolated rabbit ovarian follicles. Acta Endocrinol 1984; 107:531–537 [View Article] [PubMed]
    [Google Scholar]
  24. Smith SB, Ravel J. The vaginal microbiota, host defence and reproductive physiology. J Physiol 2017; 595:451–463 [View Article] [PubMed]
    [Google Scholar]
  25. Coleman JS, Hitti J, Bukusi EA, Mwachari C, Muliro A et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007; 21:755–759 [View Article] [PubMed]
    [Google Scholar]
  26. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001; 33:894–896 [View Article] [PubMed]
    [Google Scholar]
  27. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005; 206:306–335 [View Article] [PubMed]
    [Google Scholar]
  28. Thurm C, Schraven B, Kahlfuss S. ABC transporters in T cell-mediated physiological and pathological immune responses. Int J Mol Sci 2021; 22:9186 [View Article] [PubMed]
    [Google Scholar]
  29. Tang WW, Young MP, Mamidi A, Regla-Nava JA, Kim K et al. A mouse model of Zika virus sexual transmission and vaginal viral replication. Cell Rep 2016; 17:3091–3098 [View Article] [PubMed]
    [Google Scholar]
  30. Moulton VR. Sex Hormones in Acquired Immunity and Autoimmune Disease. Front Immunol 2018; 9:2279 [View Article] [PubMed]
    [Google Scholar]
  31. Woods MW, Zahoor MA, Lam J, Bagri P, Dupont H et al. Transcriptional response of vaginal epithelial cells to medroxyprogesterone acetate treatment results in decreased barrier integrity. J Reprod Immunol 2021; 143:103253 [View Article] [PubMed]
    [Google Scholar]
  32. Shen L, Zhang W, Yuan Y, Zhu W, Shang A. Vaginal microecological characteristics of women in different physiological and pathological period. Front Cell Infect Microbiol 2022; 12:959793 [View Article] [PubMed]
    [Google Scholar]
  33. Di Renzo GC, Giardina I, Clerici G, Brillo E, Gerli S. Progesterone in normal and pathological pregnancy. Horm Mol Biol Clin Investig 2016; 27:35–48 [View Article] [PubMed]
    [Google Scholar]
  34. Sooryanarain H, Ahmed SA, Meng XJ. Progesterone-mediated enhancement of hepatitis E virus replication in human liver cells. mBio 2021; 12:e0143421 [View Article] [PubMed]
    [Google Scholar]
  35. Debes JD, Groothuismink ZMA, de Man RA, Boonstra A. Association between a progesterone receptor mutation and hepatitis E sero-positivity in liver transplant recipients. J Med Virol 2020; 92:3871–3874 [View Article] [PubMed]
    [Google Scholar]
  36. Sayed IM, Foquet L, Verhoye L, Abravanel F, Farhoudi A et al. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Res 2017; 141:150–154 [View Article] [PubMed]
    [Google Scholar]
  37. Sayed IM, Verhoye L, Cocquerel L, Abravanel F, Foquet L et al. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut 2017; 66:920–929 [View Article] [PubMed]
    [Google Scholar]
  38. Tsarev SA, Tsareva TS, Emerson SU, Yarbough PO, Legters LJ et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol 1994; 43:135–142 [View Article] [PubMed]
    [Google Scholar]
  39. Kasorndorkbua C, Guenette DK, Huang FF, Thomas PJ, Meng X-J et al. Routes of transmission of swine hepatitis E virus in pigs. J Clin Microbiol 2004; 42:5047–5052 [View Article] [PubMed]
    [Google Scholar]
  40. Li S, Li M, He Q, Liang Z, Shu J et al. Characterization of hepatitis E virus natural infection in farmed rabbits. J Viral Hepat 2021; 28:186–195 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jgv/10.1099/jgv.0.002231
Loading
/content/journal/jgv/10.1099/jgv.0.002231
Loading

Data & Media loading...

Supplements

Supplementary material 1

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error